Industry: Machinery & Equipment
Published Date: 2025-10-14
Pages: 222 Pages
Report ld: 3529696
Request Sample
Customized Report
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Global key players of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, etc. The top five players hold a share over 49%. North America is the largest market, with a share about 44%, followed by Europe and Asia-Pacific, with share 42% and 11%, separately. In terms of product type, Human Organ and Tissue Models is the largest segment, occupied for a share of 63%.
This report aims to provide a comprehensive presentation of the global market for Microphysiological System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microphysiological System by region & country, by Type, and by End User.
The Microphysiological System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microphysiological System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microphysiological System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Microphysiological System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Microphysiological System in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview 1
1.1 Microphysiological System Product Introduction 1
1.2 Global Microphysiological System Market Size Forecast (2020-2031) 2
1.3 Microphysiological System Market Trends & Drivers 3
1.3.1 Microphysiological System Industry Trends 3
1.3.2 Microphysiological System Market Drivers & Opportunity 4
1.3.3 Microphysiological System Market Challenges 6
1.3.4 Microphysiological System Market Restraints 7
1.4 Government Policy Support for The Industry 8
1.5 Comparison of Related Technologies 10
1.6 Assumptions and Limitations 12
1.7 Study Objectives 13
1.8 Years Considered 14
2 Competitive Analysis by Company 15
2.1 Global Microphysiological System Players Revenue Ranking (2024) 15
2.2 Global Microphysiological System Revenue by Company (2020-2025) 17
2.3 Key Companies Microphysiological System Headquarters and Sales Area 19
2.4 Key Companies Microphysiological System Product Offered 21
2.5 Establish Date of Key Microphysiological System Companies 22
2.6 Microphysiological System Market Competitive Analysis 23
2.6.1 Microphysiological System Market Concentration Rate (2020-2025) 23
2.6.2 Global 3 and 5 Largest Companies by Microphysiological System Revenue in 2024 24
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2024) 25
2.7 Mergers & Acquisitions, Expansion 26
3 Segmentation by Type 37
3.1 Introduction by Type 37
3.1.1 Human Organ and Tissue Models 37
3.1.2 Disease Models 39
3.1.3 Non-Human Species Models 40
3.2 Global Microphysiological System Sales Value by Type 41
3.2.1 Global Microphysiological System Sales Value by Type (2020 VS 2024 VS 2031) 42
3.2.2 Global Microphysiological System Sales Value, by Type (2020-2031) 44
3.2.3 Global Microphysiological System Sales Value, by Type (%) (2020-2031) 44
4 Segmentation by End User 46
4.1 Introduction by End User 46
4.1.1 Pharmaceutical & Biotechnology Companies 46
4.1.2 Academic & Research Institutes 48
4.1.3 Others 49
4.2 Global Microphysiological System Sales Value by End User 50
4.2.1 Global Microphysiological System Sales Value by End User (2020 VS 2024 VS 2031) 51
4.2.2 Global Microphysiological System Sales Value, by End User (2020-2031) 53
4.2.3 Global Microphysiological System Sales Value, by End User (%) (2020-2031) 53
5 Segmentation by Region 55
5.1 Global Microphysiological System Sales Value by Region 55
5.1.1 Global Microphysiological System Sales Value by Region: 2020 VS 2024 VS 2031 55
5.1.2 Global Microphysiological System Sales Value by Region (2020-2025) 55
5.1.3 Global Microphysiological System Sales Value by Region (2026-2031) 56
5.1.4 Global Microphysiological System Sales Value by Region (%), (2020-2031) 56
5.2 North America 58
5.2.1 North America Microphysiological System Sales Value, 2020-2031 58
5.2.2 North America Microphysiological System Sales Value by Country (%), 2024 VS 2031 59
5.3 Europe 60
5.3.1 Europe Microphysiological System Sales Value, 2020-2031 60
5.3.2 Europe Microphysiological System Sales Value by Country (%), 2024 VS 2031 61
5.4 Asia Pacific 62
5.4.1 Asia Pacific Microphysiological System Sales Value, 2020-2031 62
5.4.2 Asia Pacific Microphysiological System Sales Value by Region (%), 2024 VS 2031 63
5.5 Latin America 64
5.5.1 Latin America Microphysiological System Sales Value, 2020-2031 64
5.5.2 South America Microphysiological System Sales Value by Country (%), 2024 VS 2031 65
5.6 Middle East & Africa 66
5.6.1 Middle East & Africa Microphysiological System Sales Value, 2020-2031 66
5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2024 VS 2031 67
6 Segmentation by Key Countries/Regions 68
6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2020 VS 2024 VS 2031 68
6.2 Key Countries/Regions Microphysiological System Sales Value, 2020-2031 69
6.3 United States 73
6.3.1 United States Microphysiological System Sales Value, 2020-2031 73
6.3.2 United States Microphysiological System Sales Value by Type (%), 2024 VS 2031 74
6.3.3 United States Microphysiological System Sales Value by End User, 2024 VS 2031 75
6.4 Europe 76
6.4.1 Europe Microphysiological System Sales Value, 2020-2031 76
6.4.2 Europe Microphysiological System Sales Value by Type (%), 2024 VS 2031 77
6.4.3 Europe Microphysiological System Sales Value by End User, 2024 VS 2031 78
6.5 China 79
6.5.1 China Microphysiological System Sales Value, 2020-2031 79
6.5.2 China Microphysiological System Sales Value by Type (%), 2024 VS 2031 80
6.5.3 China Microphysiological System Sales Value by End User, 2024 VS 2031 81
6.6 Japan 82
6.6.1 Japan Microphysiological System Sales Value, 2020-2031 82
6.6.2 Japan Microphysiological System Sales Value by Type (%), 2024 VS 2031 83
6.6.3 Japan Microphysiological System Sales Value by End User, 2024 VS 2031 84
6.7 Southeast Asia 85
6.7.1 Southeast Asia Microphysiological System Sales Value, 2020-2031 85
6.7.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2024 VS 2031 86
6.7.3 Southeast Asia Microphysiological System Sales Value by End User, 2024 VS 2031 87
7 Company Profiles 88
7.1 Emulate 88
7.1.1 Emulate Profile 88
7.1.2 Emulate Main Business 89
7.1.3 Emulate Microphysiological System Products, Services and Solutions 89
7.1.4 Emulate Microphysiological System Revenue (US$ Million) & (2020-2025) 91
7.1.5 Emulate Recent Developments 91
7.2 Mimetas 92
7.2.1 Mimetas Profile 92
7.2.2 Mimetas Main Business 93
7.2.3 Mimetas Microphysiological System Products, Services and Solutions 93
7.2.4 Mimetas Microphysiological System Revenue (US$ Million) & (2020-2025) 95
7.2.5 Mimetas Recent Developments 96
7.3 TissUse 97
7.3.1 TissUse Profile 97
7.3.2 TissUse Main Business 98
7.3.3 TissUse Microphysiological System Products, Services and Solutions 98
7.3.4 TissUse Microphysiological System Revenue (US$ Million) & (2020-2025) 99
7.4 InSphero 99
7.4.1 InSphero Profile 99
7.4.2 InSphero Main Business 100
7.4.3 InSphero Microphysiological System Products, Services and Solutions 100
7.4.4 InSphero Microphysiological System Revenue (US$ Million) & (2020-2025) 104
7.4.5 InSphero Recent Developments 104
7.5 Hesperos 105
7.5.1 Hesperos Profile 105
7.5.2 Hesperos Main Business 106
7.5.3 Hesperos Microphysiological System Products, Services and Solutions 106
7.5.4 Hesperos Microphysiological System Revenue (US$ Million) & (2020-2025) 109
7.5.5 Hesperos Recent Developments 109
7.6 CN Bio 110
7.6.1 CN Bio Profile 110
7.6.2 CN Bio Main Business 110
7.6.3 CN Bio Microphysiological System Products, Services and Solutions 111
7.6.4 CN Bio Microphysiological System Revenue (US$ Million) & (2020-2025) 114
7.6.5 CN Bio Recent Developments 114
7.7 TNO 115
7.7.1 TNO Profile 116
7.7.2 TNO Main Business 116
7.7.3 TNO Microphysiological System Products, Services and Solutions 117
7.7.4 TNO Microphysiological System Revenue (US$ Million) & (2020-2025) 119
7.8 28bio 119
7.8.1 28bio Profile 120
7.8.2 28bio Main Business 120
7.8.3 28bio Microphysiological System Products, Services and Solutions 121
7.8.4 28bio Microphysiological System Revenue (US$ Million) & (2020-2025) 124
7.8.5 28bio Recent Developments 124
7.9 Beijing Daxiang Biotech 125
7.9.1 Beijing Daxiang Biotech Profile 125
7.9.2 Beijing Daxiang Biotech Main Business 126
7.9.3 Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions 126
7.9.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) & (2020-2025) 128
7.10 Newcells Biotech 129
7.10.1 Newcells Biotech Profile 129
7.10.2 Newcells Biotech Main Business 129
7.10.3 Newcells Biotech Microphysiological System Products, Services and Solutions 130
7.10.4 Newcells Biotech Microphysiological System Revenue (US$ Million) & (2020-2025) 132
7.10.5 Newcells Biotech Recent Developments 132
7.11 Nortis (Quris-Al) 133
7.11.1 Nortis (Quris-Al) Profile 134
7.11.2 Nortis (Quris-Al) Main Business 134
7.11.3 Nortis (Quris-Al) Microphysiological System Products, Services and Solutions 135
7.11.4 Nortis (Quris-Al) Microphysiological System Revenue (US$ Million) & (2020-2025) 136
7.11.5 Nortis (Quris-Al) Recent Developments 137
7.12 Valo Health (TARA Biosystems) 137
7.12.1 Valo Health (TARA Biosystems) Profile 137
7.12.2 Valo Health (TARA Biosystems) Main Business 138
7.12.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions 139
7.12.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million) & (2020-2025) 140
7.12.5 Valo Health (TARA Biosystems) Recent Developments 140
7.13 Altis Biosystems 141
7.13.1 Altis Biosystems Profile 141
7.13.2 Altis Biosystems Main Business 142
7.13.3 Altis Biosystems Microphysiological System Products, Services and Solutions 143
7.13.4 Altis Biosystems Microphysiological System Revenue (US$ Million) & (2020-2025) 144
7.13.5 Altis Biosystems Recent Developments 145
7.14 Draper Laboratory 145
7.14.1 Draper Laboratory Profile 145
7.14.2 Draper Laboratory Main Business 146
7.14.3 Draper Laboratory Microphysiological System Products, Services and Solutions 147
7.14.4 Draper Laboratory Microphysiological System Revenue (US$ Million) & (2020-2025) 152
7.14.5 Draper Laboratory Recent Developments 152
7.15 Netri 153
7.15.1 Netri Profile 153
7.15.2 Netri Main Business 153
7.15.3 Netri Microphysiological System Products, Services and Solutions 154
7.15.4 Netri Microphysiological System Revenue (US$ Million) & (2020-2025) 156
7.15.5 Netri Recent Developments 157
7.16 Bi/ond 157
7.16.1 Bi/ond Profile 157
7.16.2 Bi/ond Main Business 158
7.16.3 Bi/ond Microphysiological System Products, Services and Solutions 159
7.16.4 Bi/ond Microphysiological System Revenue (US$ Million) & (2020-2025) 161
7.17 ImmuONE 161
7.17.1 ImmuONE Profile 162
7.17.2 ImmuONE Main Business 162
7.17.3 ImmuONE Microphysiological System Products, Services and Solutions 163
7.17.4 ImmuONE Microphysiological System Revenue (US$ Million) & (2020-2025) 165
7.17.5 ImmuONE Recent Developments 165
7.18 AlveoliX 166
7.18.1 AlveoliX Profile 166
7.18.2 AlveoliX Main Business 167
7.18.3 AlveoliX Microphysiological System Products, Services and Solutions 167
7.18.4 AlveoliX Microphysiological System Revenue (US$ Million) & (2020-2025) 170
7.18.5 AlveoliX Recent Developments 170
7.19 Cherry Biotech 171
7.19.1 Cherry Biotech Profile 171
7.19.2 Cherry Biotech Main Business 172
7.19.3 Cherry Biotech Microphysiological System Products, Services and Solutions 172
7.19.4 Cherry Biotech Microphysiological System Revenue (US$ Million) & (2020-2025) 174
7.19.5 Cherry Biotech Recent Developments 174
7.20 Ananda Devices 174
7.20.1 Ananda Devices Profile 175
7.20.2 Ananda Devices Main Business 175
7.20.3 Ananda Devices Microphysiological System Products, Services and Solutions 176
7.20.4 Ananda Devices Microphysiological System Revenue (US$ Million) & (2020-2025) 178
7.20.5 Ananda Devices Recent Developments 178
7.21 Obatala Sciences 179
7.21.1 Obatala Sciences Profile 179
7.21.2 Obatala Sciences Main Business 180
7.21.3 Obatala Sciences Microphysiological System Products, Services and Solutions 180
7.21.4 Obatala Sciences Microphysiological System Revenue (US$ Million) & (2020-2025) 182
7.21.5 Obatala Sciences Recent Developments 182
7.22 BiomimX 183
7.22.1 BiomimX Profile 183
7.22.2 BiomimX Main Business 183
7.22.3 BiomimX Microphysiological System Products, Services and Solutions 184
7.22.4 BiomimX Microphysiological System Revenue (US$ Million) & (2020-2025) 188
7.22.5 BiomimX Recent Developments 188
7.23 React4life 189
7.23.1 React4life Profile 189
7.23.2 React4life Main Business 189
7.23.3 React4life Microphysiological System Products, Services and Solutions 190
7.23.4 React4life Microphysiological System Revenue (US$ Million) & (2020-2025) 192
7.24 Aracari Bio 193
7.24.1 Aracari Bio Profile 193
7.24.2 Aracari Bio Main Business 193
7.24.3 Aracari Bio Microphysiological System Products, Services and Solutions 194
7.24.4 Aracari Bio Microphysiological System Revenue (US$ Million) & (2020-2025) 195
7.25 StemPharm 196
7.25.1 StemPharm Profile 196
7.25.2 StemPharm Main Business 197
7.25.3 StemPharm Microphysiological System Products, Services and Solutions 197
7.25.4 StemPharm Microphysiological System Revenue (US$ Million) & (2020-2025) 198
7.26 SynVivo 199
7.26.1 SynVivo Profile 199
7.26.2 SynVivo Main Business 199
7.26.3 SynVivo Microphysiological System Products, Services and Solutions 200
7.26.4 SynVivo Microphysiological System Revenue (US$ Million) & (2020-2025) 202
7.26.5 SynVivo Recent Developments 202
8 Industry Chain Analysis 204
8.1 Microphysiological System Industrial Chain 204
8.2 Whole Industry Chain Map 204
8.3 Microphysiological System Upstream Analysis 205
8.3.1 Upstream Analysis 205
8.3.2 Raw Materials Key Suppliers 206
8.3.3 Manufacturing Cost Structure 207
8.4 Downstream Analysis (Customers Analysis) 208
8.5 Main Business Model 209
8.6 Sales Model and Sales Channels 210
9 Research Findings and Conclusion 213
10 Appendix 215
10.1 Research Methodology 215
10.1.1 Methodology/Research Approach 215
10.1.2 Data Source 218
10.2 Author Details 221
10.3 Disclaimer 222
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 183
USD 4900.00
(Single User License)
The global Microphysiological System market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 164
USD 4250.00
(Single User License)
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 163
USD 2900.00
(Single User License)
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 175
USD 3950.00
(Single User License)
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 180
USD 3950.00
(Single User License)
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 121
USD 4250.00
(Single User License)
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-13
Pages: 177
USD 4900.00
(Single User License)
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published Date: 2025-10-13
Pages: 119
USD 2900.00
(Single User License)
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 165
USD 4350.00
(Single User License)
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 168
USD 3950.00
(Single User License)
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 183
The global Microphysiological System market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 164
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 163
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 175
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 180
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 121
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-13
Pages: 177
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published: 2025-10-13
Pages: 119
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 165
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 168
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now